Catalyst Wire Dossier Catalyst Wire Dossier

Fluticasone Propionate/Salmeterol Multidose Dry Powder Inhaler

fluticasone propionate/salmeterol · Teva Branded Pharmaceutical Products R&D, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Fluticasone Propionate/Salmeterol Multidose Dry Powder Inhaler, covering 2020-03-18 to 2020-03-18. Get the full timeline:

Most recent: Clinical Trial Update: Study of Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone Propionate/Salmeterol Multidose Dry Powder Inhaler [Phase 3]

See pricing